Skip to the page

Data / Form D filings / Normunity Holding Company, LLC

Normunity Holding Company, LLC: Form D filings

Normunity Holding Company, LLC, a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC between 2022 and 2025. The latest, on January 14, 2025, reports $37.5 million sold of a $75 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
One Beacon Street, 15th Floor, Boston, MA, 02108
Phone
(203) 435-2152
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1904252

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 14, 2025New notice$75,000,000$37,500,000$37,500,00013Jan 10, 2025sec.gov
Jan 13, 2022New notice$68,765,995$45,863,302$22,902,69313Jan 11, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David ParryDirector
Sara NayeemDirector
Timothy ShannonDirector
Sakae AsanumaDirector
Darlene Deptula-HicksExecutive Officer
Marie-Claire PeakmanDirector
Paulina HillDirector
Debanian RayDirector
Rachel HumphreyExecutive Officer, Director

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jan 13, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Normunity Holding Company, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.